Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-08

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of a fixed-dose combination of bempedoic acid plus ezetimibe versus the components and placebo in patients on m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bempedoic Acid (bempedoic acid)
  • Bempedoic acid plus ezetimibe fixed-dose combination
  • EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hyperlipidemias | Phase 3 | Status: COMPLETED | Results posted: 2020-04-08